birth control device


Also found in: Thesaurus, Acronyms.
Related to birth control device: IUCD
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.birth control device - an agent or device intended to prevent conceptionbirth control device - an agent or device intended to prevent conception
cervical cap - a contraceptive device consisting of a small thimble-shaped cup that is placed over the uterine cervix to prevent the entrance of spermatozoa
coil - a contraceptive device placed inside a woman's womb
condom, prophylactic, safe, rubber, safety - contraceptive device consisting of a sheath of thin rubber or latex that is worn over the penis during intercourse
device - an instrumentality invented for a particular purpose; "the device is small enough to wear on your wrist"; "a device intended to conserve water"
contraceptive diaphragm, pessary, diaphragm - a contraceptive device consisting of a flexible dome-shaped cup made of rubber or plastic; it is filled with spermicide and fitted over the uterine cervix
intrauterine device, IUD - contraceptive device consisting of a piece of bent plastic or metal that is inserted through the vagina into the uterus
morning-after pill - a large dose of estrogen taken orally within 24 to 72 hours after intercourse; prevents implantation of a fertilized ovum and so acts as a contraceptive; commonly used after rape or incest
anovulant, anovulatory drug, birth control pill, contraceptive pill, oral contraceptive, oral contraceptive pill, pill - a contraceptive in the form of a pill containing estrogen and progestin to inhibit ovulation and so prevent conception
spermatocide, spermicide - a contraceptive agent that kills spermatozoa
References in periodicals archive ?
All of the lawsuits similarly allege that Bayer failed to provide adequate warnings regarding the propensity of the birth control device to spontaneously migrate and cause serious Mirena complications, including uterine perforations, ectopic pregnancies and organ damage.
Nasdaq:CPTS) today announced that the July 2003 issue of Obstetrics & Gynecology (The Green Journal), a prestigious peer-reviewed journal published by the American College of Obstetricians and Gynecologists (ACOG), features data from the Pivotal trial of Essure(R), a nonincisional, permanent birth control device.
Nasdaq:CPTS), developer of the non-incisional permanent birth control procedure Essure(TM) pbc, previously known as STOP (Selective Tubal Occlusion Procedure) non-surgical permanent birth control device for women, today announced that the Company will release 2001 third quarter financial results on Wednesday, Oct.
When I developed The FemCap, my goal was to provide women with a safe and effective hormone-free birth control device.
When I developed The FemCap, my goal was to provide women with a safe, effective, hormone-free birth control device.
Nasdaq:CPTS), developer of the STOP(TM) (Selective Tubal Occlusion Procedure) non-surgical permanent birth control device for women, today announced the appointment of William H.
Currently it is involved in mass litigation involving the NuvaRing birth control device, the Yaz birth control pill, the DePuy ASR metal-on-metal hip replacements, femur fractures in Fosamax users, among other suits.
Nasdaq:CPTS), developer of the STOP(TM) (Selective Tubal Occlusion Procedure) non-surgical permanent birth control device for women, today announced that the company will release 2001 first quarter financial results on Thursday, April 26, 2001.
NASDAQ NM: CPTS), developer of the STOP(TM) (Selective Tubal Occlusion Procedure) non-surgical permanent birth control device for women, today announced the completion of a private placement of approximately 1,643,000 shares of newly issued common stock to select institutional and other accredited investors led by The Kaufmann Fund at a price of $7 per share.
Nasdaq NM:CPTS), developer of the STOP(TM) (Selective Tubal Occlusion Procedure) non-surgical permanent birth control device for women, announced that the first interim review of data from the STOP pivotal trial found a reduction in average procedure time, an increase in the rate of placement in both fallopian tubes (bilateral placement), and a decrease in the adverse event rate, when compared with interim data from the Phase II study as of March 23, 2001.
An autopsy found a blood clot had moved into the victim's lung, and the medical examiner ruled that the clot was a side effect of the birth control device.
16 /PRNewswire/ -- Product liability suits over the implantable birth control device Norplant are cropping up all over the country.